U.S. flag

An official website of the United States government

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 3

1.
Figure 3

Figure 3. From: CD4 T Cell Survival Following Intermittent IL-2 Therapy is Predictive of Increase in CD4 T Cell Count in HIV-Infected Patients.

Correlation between md for CD4 T cells and md for CD8 T cells (R=0.63, P<0.001).

Sarah W. Read, et al. J Infect Dis. ;198(6):843-850.

CitationFull text

2.
Figure 1

Figure 1. From: CD4 T Cell Survival Following Intermittent IL-2 Therapy is Predictive of Increase in CD4 T Cell Count in HIV-Infected Patients.

Correlations between md and change in T cell counts for (A) CD4 (R=-0.67; P<0.001) and (B) CD8 (R=-0.13; P=0.49).

Sarah W. Read, et al. J Infect Dis. ;198(6):843-850.

CitationFull text

3.
Figure 2

Figure 2. From: CD4 T Cell Survival Following Intermittent IL-2 Therapy is Predictive of Increase in CD4 T Cell Count in HIV-Infected Patients.

A, changes in CD4 (red) and CD8 (blue) T cell counts two months following an IL-2 cycle for 4 representative patients. Patients 33 and 9 represent patients with little or no change in CD4 count while patients 11 and 18 represent patients with robust increases in CD4 count; B, CD4 and CD8 labeling kinetics for the same representative patients (observed for up to 30 weeks post deuterium infusion). Dots represent measured fraction of labeled DNA. Solid line represents theoretical curves to match the data; C, probability density function of normal distribution of log d for CD4 and CD8. Dots on the x axis represent md.

Sarah W. Read, et al. J Infect Dis. ;198(6):843-850.

CitationFull text

Supplemental Content

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center